SIS3 for TGF-β Signaling: Applied Workflows
2026-08-09
SIS3 is a selective Smad3 inhibitor for separating canonical TGF-β signaling from Smad2 activity in fibrosis, renal, endothelial-transition, and cancer assays. This practical guide combines formulation guidance, mechanistic readouts, workflow controls, and troubleshooting with insights from a lung adenocarcinoma study.
FGFR3 Inhibition in SLC26A2 Chondrodysplasia
2026-08-08
The reference study provides genetic and pharmacological evidence that excessive FGFR3 signaling contributes to skeletal abnormalities caused by SLC26A2 deficiency. In mouse models, FGFR3 suppression and NVP-BGJ398 treatment improved chondrocyte behavior, growth-plate organization, and trabecular bone parameters, supporting a drug-repurposing strategy for rare skeletal disease research.
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-07
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with metabolic pathway modulation and cytokine quantification. The workflow preserves interactions found in human blood while providing a reproducible framework for studying how metabolic state shapes immune activation in cohort and translational research.
Patient-Derived 3D Spheroids Advance Prostate Cancer Modelin
2026-08-07
This study establishes robust patient-derived 3D spheroid cultures as a translational in vitro model for organ-confined prostate cancer. The findings enable detailed phenotypic characterization and drug response profiling, offering new avenues for preclinical research and model-guided therapy evaluation.
CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip
2026-08-06
CAY10499 enables precise, high-fidelity inhibition of hormone sensitive and monoglyceride lipases, unlocking new experimental strategies for immunometabolic and macrophage differentiation research. Its selectivity and robust inhibition profile make it an essential lipid metabolism assay reagent for dissecting disease mechanisms and metabolic signaling.
Pseudo-modified Uridine Triphosphate: Driving mRNA Synthesis
2026-08-06
Pseudo-UTP unlocks next-gen mRNA therapeutics by enabling robust, stable, and low-immunogenicity transcripts ideal for advanced vaccine and gene therapy workflows. Cutting-edge studies now reveal how pseudouridine modification radically improves RNA performance in complex disease models—ushering in new standards for experimental precision and translational impact.
Epalrestat in Translational Neuroprotection: Pathways and Pr
2026-08-05
Explore how Epalrestat, a leading aldose reductase inhibitor, advances neurodegenerative disease and oxidative stress research. This article uniquely dissects real-world experimental protocols and the KEAP1/Nrf2 pathway, providing deeper insights for translational applications.
Inducing Right Ventricular Cardiomyocytes from Human PSCs
2026-08-05
Saito et al. introduce a robust protocol for deriving right ventricular-like cardiomyocytes from human pluripotent stem cells by modulating BMP signaling during mesoderm induction. This chamber-specific differentiation advances cardiac disease modeling and enhances the precision of in vitro studies targeting right ventricular pathophysiology.
AIBP-LRP2–HDL Axis Restricts CXCR4+ Capillary Expansion in I
2026-08-04
Zhu et al. reveal a two-phase mechanism in which AIBP-LRP2–mediated HDL uptake limits expansion of CXCR4+ stem-like capillary endothelial cells, thereby restraining collateral vessel growth in ischemic tissue. This work clarifies molecular links between lipid metabolism and vascular remodeling, suggesting new targets for therapeutic revascularization.
Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera
2026-08-04
This article reviews the medicinal chemistry study identifying a new scaffold of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, notably compound 8c, which demonstrates nanomolar potency, selectivity, and metabolic stability. These findings advance our understanding of PDH activation and mitochondrial metabolism, with implications for metabolic, allergic, and cancer disease models.
L-Threonine in Translational Metabolism: From Mechanism to I
2026-08-03
Explore how L-Threonine, a central amino acid, powers next-generation metabolic and signaling research. This article provides mechanistic insights, protocol parameters, and strategic guidance for translational researchers, spotlighting APExBIO's L-Threonine and bridging recent nanozyme findings to metabolic profiling and cell culture optimization.
Smad3 Inhibition Reduces ADAMTS-5 in Early Osteoarthritis Mo
2026-08-03
Xiang et al. demonstrate that targeted inhibition of Smad3 significantly downregulates ADAMTS-5 expression in early-stage osteoarthritis, partly by upregulating miRNA-140. These findings clarify the molecular crosstalk in TGF-β signaling and suggest new experimental directions for cartilage and fibrosis research.
Masitinib (AB1010): Parameters for KIT/PDGFR Inhibition Work
2026-08-02
Masitinib (AB1010) is a phenylaminothiazole-type tyrosine kinase inhibitor designed for selective inhibition of KIT, PDGFRα, and PDGFRβ, providing precise pathway targeting in cancer, mastocytosis, and inflammatory disease research. It is best used in DMSO-based workflows and is inappropriate for protocols requiring aqueous or ethanol solubility, or broad-spectrum kinase inhibition.
PA-824: Mechanistic Insights and Translational Potential in
2026-08-01
Explore the unique mechanistic profile of PA-824, a bicyclic nitroimidazole derivative, and discover how its dual action transforms tuberculosis research. This article delivers unprecedented depth on PA-824’s molecular mechanism and its impact on rational drug regimen design.
BIBR 1532 Telomerase Inhibitor: Advanced Workflows & Trouble
2026-07-31
BIBR 1532, a selective telomerase inhibitor from APExBIO, empowers precise modulation of telomerase activity with robust, reproducible workflows. This guide translates recent synergy-driven telomere attrition research into actionable protocols and troubleshooting strategies for oncology labs.
458 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page